Finance

Beta
Lists
Equity sectors
Symbols
Symbols
Price
Change
% Change
Trend
Prev Close
Open
High
Low
Volume
Mkt Cap
SIXB
Materials
SIXB
Materials
SIXB
+0.36%
1,089.71
+3.90
+0.36%
—1,085.811,083.231,092.001,074.08——
SIXC
Communications
SIXC
Communications
SIXC
+0.11%
608.33
+0.64
+0.11%
—607.69607.69609.89604.02——
SIXE
Energy
SIXE
Energy
SIXE
+0.14%
1,194.04
+1.66
+0.14%
—1,192.381,200.061,206.851,186.65——
SIXI
Industrials
SIXI
Industrials
SIXI
-0.01%
1,756.28
-0.11
-0.01%
—1,756.391,753.531,760.321,733.52——
SIXM
Financials
SIXM
Financials
SIXM
-0.42%
630.64
-2.63
-0.42%
—633.27631.36633.90628.75——
SIXR
Staples
SIXR
Staples
SIXR
+0.07%
853.01
+0.59
+0.07%
—852.42853.25856.20850.72——
SIXRE
Real estate
SIXRE
Real estate
SIXRE
+0.05%
218.91
+0.12
+0.05%
—218.79218.79219.49217.26——
SIXT
Technology
SIXT
Technology
SIXT
+1.50%
3,767.54
+55.85
+1.50%
—3,711.693,719.293,776.213,699.88——
SIXU
Utilities
SIXU
Utilities
SIXU
-0.39%
907.48
-3.57
-0.39%
—911.05909.99913.34902.56——
SIXV
Health care
SIXV
Health care
SIXV
+1.26%
1,519.64
+18.98
+1.26%
—1,500.661,504.161,526.631,504.16——
SIXY
Discretionary
SIXY
Discretionary
SIXY
+0.08%
2,457.01
+2.05
+0.08%
—2,454.962,450.632,458.572,435.72——
DPM:FRA
Sumitomo Pharma Co Ltd
€8.07
-0.37%
(-0.030) 1D
May 28, 8:07:09 AM GMT+2  ·   EUR
All symbols
SymbolPriceChange% Change
Generating top insights for DPM...
Open
€8.07
High
€8.07
Low
€8.07
Mkt. cap
675.38B
Avg. vol.
144.00
Volume
0.00
52-wk high
€18.80
52-wk low
€4.62
No. of employees
4K
News stories
From sources across the web
Profile
Sumitomo Pharma Company Limited is a Japanese multinational pharmaceutical company. The company is focused on oncology, psychiatry, neurology, women's health issues, urological diseases among other areas. Its headquarters are located in Chuo-ku, Osaka. Wikipedia
About Sumitomo Pharma Co Ltd
CEO-
Employees3.83K
FoundedMay 14, 1897
HeadquartersOsaka, Osaka, Japan
SectorPharmaceutical industry
Previous reportsAll values in JPY
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in JPY
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
108.00B
119.12B
120.62B
105.55B
Cost of goods sold
44.11B
45.59B
55.44B
51.26B
Cost of revenue
44.11B
45.59B
55.44B
51.26B
Research and development expenses
8.18B
9.35B
10.35B
16.12B
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
35.66B
40.90B
42.94B
43.14B
Operating expense
42.85B
-1.04B
52.19B
110.08B
Total operating expenses
86.96B
44.55B
107.63B
161.34B
Operating income
21.04B
74.57B
13.00B
-55.72B
Other non operating income
-
-
-
-
EBT including unusual items
11.93B
80.87B
8.74B
-1.20B
EBT excluding unusual items
11.93B
80.87B
8.74B
-53.43B
Income tax expense
726.00M
-6.78B
-80.00M
-383.00M
Effective tax rate
6.08%
-8.39%
-0.92%
32.05%
Other operating expenses
-980.00M
-51.30B
-1.10B
50.82B
Net income
11.21B
87.65B
8.82B
-812.00M
Net profit margin
10.38%
73.58%
7.31%
-0.77%
Earnings per share
-
-
-
-
Interest and investment income
585.00M
5.11B
258.00M
1.70B
Interest expense
-9.05B
-
-5.14B
-460.00M
Net interest expenses
-8.47B
5.11B
-4.88B
1.24B
Depreciation and amortization charges
-
-
-
-
EBITDA
26.24B
79.85B
18.32B
-50.80B
Gain or loss from assets sale
-
1.96B
-
-
AI content may include mistakes. Learn more

Research

AI content may include mistakes. Learn more